Nanalysis Announces Annual General Meeting
Meeting to Be Held on Wednesday, June 28th at 9:00 AM MDT
CALGARY, AB, June 15, 2023 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications, announces that the Annual General Meeting (AGM) will take place on Wednesday June 28, 2023, at 9 AM MDT at Bay 1, 4600 – 5th Street NE, Calgary, Alberta, T2E 7C3. Following the formal part of the meeting, Sean Krakiwsky, President and Chief Executive Officer of the Corporation, will provide a corporate presentation.
The Company strongly encourages all shareholders to vote by proxy or by voting instruction rather than attend the meeting in person. All shareholders and proxyholders are encouraged to view the meeting in real time via preferred video conference: https://zoom.us/j/91860423336 or dial in via phone (international dial-in numbers found at https://zoom.us/u/aNcVqmLSU, Conference ID: 918 6042 3336). Shareholders will not be able to vote through the teleconference line or video link.
We kindly ask that all attendees remain muted until the Q&A session and to follow instructions provided on the call to avoid interruption.
Nanalysis' business is what we term "MRI and NMR for industry". The Company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The company has followed-up that initial offering with new products and continues to have a strong innovation pipeline. In 2020 Nanalysis announced the launch of its 100MHz device, the most powerful and most advanced compact NMR device ever brought to market.
Nanalysis' devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company continues to exploit new global market opportunities independently and with partners.
In 2022 the Company acquired K'(Prime) Technologies Inc. (K'Prime), a North American sales and service company which provides sales services for scientific instrumentation for pharma, food, chemical and oil & gas customers, as well as imaging systems for security applications. K'Prime's service organization provides airport and commercial security installation and maintenance solutions across North America.
Additionally in 2022, the Company acquired a 43% ownership in Quad Systems AG ("Quad Systems"), a Zurich-based Nuclear Magnetic Resonance (NMR) company focused on high-field NMR for pharmaceutical and other vertical markets.
This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
SOURCE Nanalysis Scientific Corp.
Contacts: Matthew Selinger, Firm IR Group, 415-572-8152, [email protected]
Share this article